166 related articles for article (PubMed ID: 35663983)
1. Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection.
Liang W; Li X; Wang H; Nie K; Meng Q; He J; Zheng C
Front Immunol; 2022; 13():892350. PubMed ID: 35663983
[TBL] [Abstract][Full Text] [Related]
2. Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection.
Liang W; Li X; Yao Y; Meng Q; Wu X; Wang H; Xue J
Front Pharmacol; 2022; 13():921517. PubMed ID: 35677450
[TBL] [Abstract][Full Text] [Related]
3. Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
Qin X; Huang C; Wu K; Li Y; Liang X; Su M; Li R
J Cell Mol Med; 2021 Jan; 25(2):677-685. PubMed ID: 33241658
[TBL] [Abstract][Full Text] [Related]
4. Detection of Hantavirus during the COVID-19 Pandemic, Arizona, USA, 2020.
Hecht G; Dale AP; Ruberto I; Adame G; Close R; Snyder SJ; Pink K; Lemmon N; Rudolfo J; Madsen M; Wiens AL; Cossaboom C; Shoemaker T; Choi MJ; Cannon D; Krapiunaya I; Whitmer S; Mobley M; Talundzic E; Klena JD; Venkat H
Emerg Infect Dis; 2023 Aug; 29(8):1663-1667. PubMed ID: 37486231
[TBL] [Abstract][Full Text] [Related]
5. Quercetin for COVID-19 and DENGUE co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and DENV.
Zheng W; Wu H; Wang T; Zhan S; Liu X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34058750
[TBL] [Abstract][Full Text] [Related]
6. Hantavirus Pulmonary Syndrome in a COVID-19 Patient, Argentina, 2020.
Coelho RM; Periolo N; Duhalde CP; Alonso DO; Bellomo CM; Corazza M; Iglesias AA; Martinez VP
Emerg Infect Dis; 2022 Apr; 28(4):876-878. PubMed ID: 35203110
[TBL] [Abstract][Full Text] [Related]
7. Case Report: First Confirmed Case of Coinfection of SARS-CoV-2 With
Hesse S; Nuñez H; Salazar JR; Salinas TP; Barrera E; Chong R; Torres S; Cumbrera A; Olivares I; Junco A; Matteo C; González C; Chavarría O; Moreno A; Góndola J; Ábrego L; Díaz Y; Pitti Y; Franco D; Martínez-Montero M; Pascale JM; López-Vergès S; Martínez AA; Armién B
Front Trop Dis; 2021; 2():769330. PubMed ID: 34851327
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Hantavirus Cardiopulmonary Syndrome Diagnostic in the Face of the COVID-19 Pandemic.
de Lemos ERS; Fernandes J; Coelho TA; Lumi LO; Rosa JAR; Biasus L; Alves Nunes ZM; Brack DB; de Oliveira RC
Am J Trop Med Hyg; 2022 Jan; 106(3):870-873. PubMed ID: 35045387
[TBL] [Abstract][Full Text] [Related]
9. Hantavirus Disease and COVID-19.
Joyce AK; Oliver TT; Kofman AD; Talker DL; Safaeian S; Peker Barclift D; Perricone AJ; D'Andrea SM; Whitesell AN; Yazzie D; Guarner J; Saleki M; Ingall GB; Choi MJ; Antone-Nez R
Am J Clin Pathol; 2022 Mar; 157(3):470-475. PubMed ID: 34643226
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
11. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
12. Exploration of molecular targets and mechanisms of Chinese medicinal formula Acacia Catechu -Scutellariae Radix in the treatment of COVID-19 by a systems pharmacology strategy.
Feng T; Zhang M; Xu Q; Song F; Wang L; Gai S; Tang H; Wang S; Zhou L; Li H
Phytother Res; 2022 Nov; 36(11):4210-4229. PubMed ID: 35859316
[TBL] [Abstract][Full Text] [Related]
13. Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses.
Zheng W; Wu H; Liu C; Yan Q; Wang T; Wu P; Liu X; Jiang Y; Zhan S
Front Immunol; 2021; 12():707287. PubMed ID: 34394108
[TBL] [Abstract][Full Text] [Related]
14. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
15. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
16. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
18. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
19. Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019.
Wang T; Zhao M; Ye P; Wang Q; Zhao Y
Arch Med Res; 2021 Apr; 52(3):304-310. PubMed ID: 33309308
[TBL] [Abstract][Full Text] [Related]
20. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
